Guillaume Copart
Expert Contributor
Guillaume Copart
Founder and CEO
Global Health Intelligence
https://www.linkedin.com/in/guillaume-corpart-26116a3/
https://globalhealthintelligence.com/es/
1
The future has arrived and it is now part of daily life, thanks to a range of technological innovations, writes Guillaume Corpart.
SOMIB_HerbertBravo
View from the Top
Herberth Bravo
President
SOMIB
Biomedical engineers are key in healthcare. Amid the COVID-19 crisis, their work can make the difference in critical cases.
Andrés Ferrara
View from the Top
Andrés Ferrara
Director General
Analitek
Analitek, founded in 1994 in Monterrey, supplies analytics solutions for a variety of industries.
While the world waits on the next big cure or treatment in medicine, pioneers in the field are working to deliver just that.
Analysis
“Over the next few years we will be looking into biosimilars, a growing niche believed to be the future of the pharmaceutical industry”
Carlos Sánchez
View from the Top
Carlos Sánchez
Carlos Sánchez
R&D Manager
MyHeart
Our products offer almost immediate data to patients regarding their health allowing them to seek treatment quicker.
Joel Osorio
View from the Top
Joel Osorio
Director General
RegenerAge
Smart prevention is the best treatment for any disease
José Islas
View from the Top
José Islas
Director General
IVINSEMER
Preimplantation genetic diagnosis has had positive results in the market
Edna Álvarez
View from the Top
Adna Álvarez
Latin America Manager
Malvern Panalytical
Our investment continues with the launch of a Spanish website earlier this year.
Thomas Cantor
View from the Top
Thomas Cantor
Founder and President
Scantibodies
is is a great advantage to us because investors want to make the decisions for the company and are just concerned with money, which is not our goal.
Subscribe to Biomedicine